CoreAge Rx vs Roen Rx
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Roen Rx head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
Roen Rx
FDA warning letter, June 2026 — issued to Roen Health, Inc. dba RoenRx. See the FDA's warning letter database.
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 60 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Roen Rx a bad call — it's best for people comparing insurance coordination with a compounded-medication bundle who confirm the exact plan, dose fees and refund rules. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Roen Rx |
|---|---|---|
| Brief Score | 94/100 (A) | 60/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Bundle $217 first month; then $297 Includes care and prescribed medication; exact dose/supply and higher-dose fees unconfirmed. Separate $39 care-only membership excludes medication; medication-only headline from $151/mo is not the bundle total. Government-insurance users excluded. Bundle nonapproval refund promise differs from general nonrefundable consultation/membership terms; cancel before renewal to stop future charges. Full price detailsBranded and compounded semaglutide options offered; complete selected-plan quote unknown; care-only membership $39 first month plus separate medication, compounded medication from $151/month on three-month purchase, bundled plan $217 first month then $297 with medication included |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Bundle $349 first month; then $449 Includes care and prescribed medication; exact dose/supply and higher-dose fees unconfirmed. Separate $39 care-only membership excludes medication; medication-only headline from $216/mo is not the bundle total. Government-insurance users excluded. Bundle nonapproval refund promise differs from general nonrefundable consultation/membership terms; cancel before renewal to stop future charges. Full price detailsBranded and compounded tirzepatide options offered; complete selected-plan quote unknown; care-only membership $39 first month plus separate medication, compounded medication from $216/month depending on plan, bundled plan $349 first month then $449 with medication included |
| Coverage | US only; restrictions by state, confirmed at intake | Patient-state clinician and pharmacy eligibility need confirmation; FAQ excludes people using government insurance such as Medicare or Medicaid |
| Brand-name access | Not confirmed | Yes |
| Oral / sublingual | Injection only | Unconfirmed |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Roen Rx: Bundles: semaglutide $217 then $297; tirzepatide $349 then $449. Separate $39 care-only offer excludes medication. Higher-dose fees possible; clinical-ineligibility refund promise conflicts with general terms.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.